)
)11.3.14
1.3.14
Invasive Micropapillary Carcinoma of the Breast
Definition
- Breast carcinoma with a prominent (pseudo) micropapillary pattern
Diagnostic Criteria
- Numerous small pseudo-papillary clusters of cells
- No fibrovascular cores
- Frequent central lumen formation in clusters
- Peripherally located nuclei frequently bulge out with knobby appearance, "the hedgehog" tumor
- Clusters surrounded by clear spaces
- One or only a few clusters per space
- Scant mucin rarely detectable in spaces
- Spaces surrounded by loose fibrocollagenous stroma
- Frequent high nuclear grade reported in some series
- Frequently has abundant eosinophilic cytoplasm
- Frequent lymphatic involvement
- Occasional psammoma bodies
- Associated DCIS may be of various types
- Not related to micropapillary DCIS
- Pattern may be predominant or focal
- No clinical difference between predominant and focal cases
- No reported cutoff for minimal significant amount of pattern
- Report such cases as mixed
- Frequently mixed with infiltrating ductal carcinoma
- Rarely mixed with other type
Clinical
- Incidence
- Pure about 1%
- Mixed about 4-7%
- Frequent local recurrence (70-90%)
- Poor prognosis
- Approximate 40% dead of disease in three years
- Not independent of stage
- Linked to high incidence of nodal involvement
- Rare cases reported in males
Grading / Staging / Report
Grading
- Bloom-Scarff-Richardson grading scheme is most widely used
- Total score and each of the three components should be reported
- Based on invasive area only
Tubule formation | Score |
---|---|
>75% tubules | 1 |
10-75% tubules | 2 |
<10 span="" tubules="">10> | 3 |
Nuclear pleomorphism (most anaplastic area) | Score |
---|---|
Small, regular, uniform nuclei, uniform chromatin | 1 |
Moderate varibility in size and shape, vesicular, with visible nucleoli | 2 |
Marked variation, vesicular, often with multiple nucleoli | 3 |
Mitotic figure count per 10 40x fields (depends on area of field, see key below) | Score | ||||
---|---|---|---|---|---|
0.096 mm2 | 0.12 mm2 | 0.16 mm2 | 0.27 mm2 | 0.31 mm2 | |
0-3 | 0-4 | 0-5 | 0-9 | 0-11 | 1 |
4-7 | 5-8 | 6-10 | 10-19 | 12-22 | 2 |
>7 | >8 | >10 | >19 | >22 | 3 |
- Olympus BX50, BX40 or BH2 or AO or Nikon with 15x eyepiece: 0.096 mm2
- AO with 10x eyepiece: 0.12 mm2
- Nikon or Olympus with 10x eyepiece: 0.16 mm2
- Leitz Ortholux: 0.27 mm2
- Leitz Diaplan: 0.31 mm2
- Mitotic count figures based on original data presented for Leitz Ortholux by Elston and Ellis 1991, with modifications based on pubished and measured areas of view
- Evaluate regions of most active growth, usually in cellular areas at periphery
- We employ strict criteria for identification of mitotic figures
Sum of above three components | Overall grade |
---|---|
3-5 points | Grade I (well differentiated) |
6-7 points | Grade II (moderately differentiated) |
8-9 points | Grade III (poorly differentiated) |
Staging
- Micropapillary carcinoma is associated with frequent lymph node metastases
- Seen even with primary tumors <1 cm="" span="">1>
- Seen even with mixed tumors with small micropapillary component
- Nodal involvement is frequently by micrometastases
- TNM staging is the most widely used scheme for breast carcinomas but is not universally employed
- Critical staging criteria for regional lymph nodes
- Isolated tumor cell clusters
- Usually identified by immunohistochemistry
- Term also applies if cells identified by close examination of H&E stain
- No cluster may be greater than 0.2 mm
- Multiple such clusters may be present in the same or other nodes
- Usually identified by immunohistochemistry
- Micrometastasis
- Greater than 0.2 mm, none greater than 2.0 mm
- Metastasis
- At least one carcinoma focus over 2.0 mm
- If one node qualifies as >2.0 mm, count all other nodes even with smaller foci as involved
- Critical numbers of involved nodes: 1-3, 4-9 and 10 and over
- At least one carcinoma focus over 2.0 mm
- Note extranodal extension
- Isolated tumor cell clusters
Report
- Excisions: the following are important elements that must be addressed in the report for infiltrative breast carcinomas
- Grade
- Total score and individual components
- Size of neoplasm
- Give 3 dimensions or greatest dimension
- Critical cutoffs occur at 0.5 cm and at 2 cm
- Margins of resection
- Measure and report the actual distance of both invasive and in situ carcinoma
- Angiolymphatic invasion
- Indicate if confined to tumor mass, outside tumor mass or in dermis
- (Extensive DCIS is not currently felt to be a significant predictor of behavior)
- Results of special studies performed for diagnosis
- Results of prognostic special studies performed
- ER, PR, Proliferation marker, Her2neu
- If studies were performed on a prior specimen, refer to that report and give results
- Grade
- Needle or core biopsies
- Provisional grade may be given but may defer to excision for definitive grade
- Presence of absence of angiolymphatic invasion
- Results of special studies performed for diagnosis
- Results of prognostic special studies if performed
- ER, PR, Proliferation marker, Her2neu
- State if studies are deferred for a later excision specimen
- Regional lymph nodes
- Report findings as described above
Subscribe to:
Posts (Atom)
List of all the posts
- a common misdiagnosis. (2)
- ASAP in prostate needle biopsy. (1)
- breast (3)
- Breast Biopsy Procedure (3)
- breast cancer (2)
- Breast Carcinoma vs. Pulmonary Adenocarcinoma (2)
- carcinoma (2)
- core boiopsy. (1)
- Desmoplastic melanoma (1)
- Dysplasia in Inflammatory Bowel Disease (1)
- Errors in Surgical Pathology (1)
- False positive diagnosis in breast FNAC. (1)
- FNAC (1)
- Guidelines for Radical Prostatectomy Surgical Specimen Handling (1)
- High Grade Prostatic Intraepithelial Neoplasia (HGPIN) (1)
- Immunohistochemistry in Follicular lymphoid lesions. (1)
- Immunopheotype of Gastrointestinal stromal tumours (GIST) (1)
- Importance of Tissue fixation in Cancer management (1)
- Introduction (1)
- lymph node biopsy (1)
- lymphoma (1)
- Making Sure Your Lab Reports Are Easy to Understand (1)
- Measuring size of DCIS (1)
- Microcystic adenocarcinoma of the prostate-pseudobenign carcinoma (1)
- micropapillary (1)
- Mimics of Prostate cancer (1)
- Molecular Cancer Pathology Update (1)
- Papillary Thyroid Ca Criteria (1)
- poor prognosis (1)
- Protocol for Synpotic reporting of Breast excision specimen with diagnosis of Ductal Carcinoma In Situ (DCIS) of the Breast (1)
- Quality Management Requirements for HER2/neu Marker in Breast Cancer (1)
- Quirke's Method For Dissecting Colorectal Adenocarcinoma (1)
- Reporting parameters for positive prostate needle biopsy (1)
- Research (1)
- Sentinel Lymph Node Biopsy -Malignant Melanoma (1)
- Sentinel Lymph Node Mapping-Pathology Protocol in Breast Cancer (1)
- Synoptic reporting of cancer (1)
- Updates on Molecular Cancer pathology (1)
- Work up of Carcinoma of Unknown Primary (CUP) (1)